Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Selvig

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|January 1, 1981
Pharmacokinetics of proxyphylline in adults after intravenous and oral administrationK Selvig
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1982
Metabolism of proxyphylline in man: urinary excretion of proxyphylline and its metabolitesK Selvig
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 10, 1978
[Chloroquine/oxychloroquine]K Selvig, E Munthe
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1977
Determination of serum proxiphylline by high-pressure liquid chromatographyK Selvig, K S Bjerve
Acta Pharmacologica Et Toxicologica|September 1, 1982
Inhibition of human lung cyclic nucleotide phosphodiesterases by proxyphylline, theophylline and their metabolitesK Selvig, K S Bjerve
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1980
Metabolism of proxyphylline in man. Isolation and identification of metabolites in urineK Selvig, K S Bjerve
The American Journal of Forensic Medicine and Pathology|September 1, 1986
A case of fluoride poisoningE Kaa, K Selvig, H Dybdahl, et al.
Journal of Medicinal Chemistry|October 1, 1983
Optical resolution, absolute configuration, and activity of the enantiomers of proxyphyllineK Selvig, M Ruud-Christensen, A J Aasen
Acta Paediatrica Scandinavica|November 1, 1981
Evaluation of a new sustained-release theophylline tablet for childrenK Selvig, A Alme, H E Rugstad, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 30, 1980
[Use of theophylline and proxyphylline in the treatment of obstructive lung diseases in children: demands for new dosage routines]T L Holmen, K Selvig, K S Bjerve, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|January 1, 1981
Pharmacokinetics of proxyphylline in adults after intravenous and oral administrationK Selvig
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1982
Metabolism of proxyphylline in man: urinary excretion of proxyphylline and its metabolitesK Selvig
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 10, 1978
[Chloroquine/oxychloroquine]K Selvig, E Munthe
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1977
Determination of serum proxiphylline by high-pressure liquid chromatographyK Selvig, K S Bjerve
Acta Pharmacologica Et Toxicologica|September 1, 1982
Inhibition of human lung cyclic nucleotide phosphodiesterases by proxyphylline, theophylline and their metabolitesK Selvig, K S Bjerve
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1980
Metabolism of proxyphylline in man. Isolation and identification of metabolites in urineK Selvig, K S Bjerve
The American Journal of Forensic Medicine and Pathology|September 1, 1986
A case of fluoride poisoningE Kaa, K Selvig, H Dybdahl, et al.
Journal of Medicinal Chemistry|October 1, 1983
Optical resolution, absolute configuration, and activity of the enantiomers of proxyphyllineK Selvig, M Ruud-Christensen, A J Aasen
Acta Paediatrica Scandinavica|November 1, 1981
Evaluation of a new sustained-release theophylline tablet for childrenK Selvig, A Alme, H E Rugstad, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 30, 1980
[Use of theophylline and proxyphylline in the treatment of obstructive lung diseases in children: demands for new dosage routines]T L Holmen, K Selvig, K S Bjerve, et al.
Pageof 2